Company

Milo Biotechnology Inc.

Milo Biotechnology develops gene therapies for rare neuromuscular diseases.

About

Milo Biotechnology develops gene therapies for rare neuromuscular diseases, including Amyotrophic Lateral Sclerosis (ALS). Founded in 2012, the company is based in Cleveland Heights, US. Its founders are Al Hawkins, Brian Kaspar, and Paul Hawkins. On September 20, 2016, it raised USD 0.8 mn from Jumpstart Limited and Rev1 Ventures.

4Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in